神经生物标志物市场规模报告| 2027 年全球预测

  • Report Code : TIPRE00003515
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 168
Buy Now

[研究报告] 预计到 2027 年,神经生物标志物市场将从 5,501.8 美元增至 14,454.7 百万美元2019 年将达到 100 万美元。预计 2020 年至 2027 年该市场将以 13.0% 的复合年增长率增长。

市场洞察和分析师观点:

生物标志物是表明疾病存在的分子。神经系统疾病的生物标志物在早期并不那么容易获得。然而,技术的进步使得通过测量生物标志物来跟踪大脑的健康状况成为可能。这有助于及早发现疾病、进行侵入性较小的诊断,并加快药物开发速度,有望成为有效的治疗方法。该市场是由神经系统疾病患病率上升和对神经生物标志物研究的日益关注等因素推动的。然而,与生物标志物相关的担忧可能会阻碍预测期内的市场增长。

增长动力和挑战:

神经系统疾病在疾病诊断、治疗和管理方面给卫生系统带来了巨大负担。一些主要的神经系统疾病是癫痫、阿尔茨海默病、多发性硬化症、脊髓性肌萎缩症(SMA)、杜氏肌营养不良症等。老年人群易患神经系统疾病。神经病、帕金森病、阿尔茨海默病和肌张力障碍是影响老年人的最常见的神经系统疾病。根据美国国立卫生研究院 (NIH) 的数据,全球 8.5% 的人口(即约 6.17 亿人)年龄在 65 岁及以上。根据世界卫生组织 (WHO) 的数据,神经系统疾病占全球疾病负担的 6.3%,是全球死亡的主要原因之一。此外,据报道,发达国家13.2%的死亡和中低收入国家16.8%的死亡是由于神经系统疾病造成的。

医疗保健和药物研发领域的快速发展正在导致引入新的治疗解决方案来治疗神经系统疾病。世界卫生组织、国家神经疾病和中风研究所以及美国国立卫生研究院等权威机构正在采取建设性措施,鼓励研究活动并寻找治疗神经系统疾病的药物。美国国家神经疾病和中风研究所 (NINDS) 生物标志物项目致力于提高神经治疗临床研究的质量和效率,并支持生物标志物验证。该计划通过为研究活动提供资金来促进严格的生物标志物识别和验证。神经退行性疾病生物标志物 (BAND) 是一项旨在促进对阿尔茨海默病 (AD)、帕金森病 (PD) 和其他神经退行性疾病的研究分析的计划。阿尔茨海默病协会、英国阿尔茨海默病研究中心 (ARUK)、迈克尔 J. 福克斯帕金森病研究基金会 (MJFF) 和韦斯顿大脑研究所 (Weston) 资助了该计划下的多个奖项。< /p>

生物标志物的测量错误可能会导致有关疾病的错误结果。除实验室误差外,还有多种类型的测量误差。样品采集不当或标本运输不当会影响样品的测量。由于生物标志物源自人体组织或体液,因此神经生物标志物与一定程度的健康风险相关。血液和尿液等体液中的生物标志物通常具有良好的耐受性。成本是生物标志物研究的一个主要问题。如果临床试验包括数千名受试者,则生物标志物研究的成本可能会非常高。 ‘误报’和“假阴性”研究结果会产生额外的工作,并且只会增加研究的总体成本。

战略见解

报告细分和范围:

“全球神经生物标志物市场”根据产品、应用程序、最终用户和地理位置进行细分。根据产品,神经生物标志物市场分为蛋白质组学、基因组学、代谢组学、成像等。根据应用,市场已细分为阿尔茨海默病、帕金森病、精神分裂症、亨廷顿病、脊髓性肌萎缩症等。根据最终用户,神经生物标志物市场分为制药和生物技术公司、临床诊断和研究组织。基于地理位置的神经生物标志物市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国、亚太地区其他地区)、中东和美国非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)

细分分析:

根据产品,分为蛋白质组学生物标志物、基因组学生物标志物、代谢组学生物标志物、成像生物标志物等。 2019年,基因组生物标志物领域占据了最大的神经生物标志物市场份额,并且预计该领域在预测期内将以最快的速度增长。基因组学在基于个体遗传变异的个性化诊断和治疗方面取得了实质性进展。基因组生物标志物已证明可用于识别神经系统疾病,例如帕金森病、阿尔茨海默病、亨廷顿病、自闭症等。用于神经系统疾病诊断和治疗应用的个性化药物和基因分析的不断出现预计将在未来几年促进该领域的增长。

神经生物标志物市场(按产品) 2019年和2027年

应用领域分为阿尔茨海默病和阿尔茨海默病。斯氏病、帕金森病、精神分裂症、亨廷顿病、脊髓性肌萎缩症等。阿尔茨海默病细分市场在 2019 年占据了神经生物标志物市场的最高份额,预计该细分市场在 2020 年至 2027 年期间将出现显着增长。阿尔茨海默病是指导致脑细胞丧失功能的进行性疾病。消瘦(退化)并最终死亡。随着疾病的发展,患者会出现严重的记忆障碍和执行日常任务的能力。目前可用的药物可能会暂时改善症状或减缓病情恶化的速度。该疾病发病率的增加预计将导致未来几年神经生物标志物市场的增长。根据最终用户,市场分为制药和生物技术公司、临床诊断和研究组织。 2019年,制药和生物技术公司细分市场占据最大的市场份额,预计该细分市场在未来几年也将以最快的速度增长。因此,上述因素导致了神经生物标志物市场规模的增长。

区域分析:

根据地理位置,神经生物标志物市场分为五个关键区域:北美、欧洲、亚太地区、南美洲和南美洲。中美洲、中东和非洲非洲。基于三个主要国家对北美神经生物标志物市场进行了分析——美国、加拿大和墨西哥。据估计,美国神经生物标志物市场在预测期内将占据最大的神经生物标志物市场份额。美国神经生物标志物市场的增长归因于市场参与者采用有机和无机策略来发展市场。例如,2020 年 5 月,Quanterix Corporation(一家将生物标志物分析数字化以推进精准健康科学的公司)宣布,将扩展其强大的即用型 Simoa 试剂盒菜单,将苏氨酸 181 处磷酸化的 tau (p-tau181) 纳入其中),一种用于研究阿尔茨海默病病理学的高度特异性生物标志物,存在于脑脊液(CSF)、血清和血浆中。据阿尔茨海默病协会统计,到 2020 年,估计有 580 万 65 岁或以上的美国人患有阿尔茨海默病,预计到 2050 年这一数字将达到 1,380 万。因此,神经系统疾病的日益流行可能有利于市场在预测期内的增长。

欧洲是全球神经生物标志物市场的第二领先地区。由于该地区采用先进的诊断和治疗技术,德国在预测期内在欧洲神经生物标志物市场中占据最大份额。德国医疗保健当局和政府正在允许研究机构和市场公司在该国进行研究。预计此类战略将加速该国参与开发和采用推荐用于神经系统疾病诊断和治疗的创新技术。由于人口老龄化和遗传性疾病数量的增加,德国罕见神经系统疾病的患病率正在增加。预计德国神经介入设备市场在预测期内将大幅增长。该国的中风死亡率也很高,每年有75,861人死于中风。据估计,到2035年底,德国中风的发病率预计将增加30%。此外,到2035年,患病率和死亡率预计将分别上升至19%和40%。

此外,亚太地区预计将成为所有其他地区中增长最快的地区。由于对优质诊断和治疗解决方案的需求不断增加、神经系统疾病患病率不断上升以及对研发活动的日益关注等因素,亚太地区市场的增长预计将以更快的速度增长。此外,发展医疗基础设施和增加投资以促进研究活动预计将在预测期内推动亚太地区神经生物标志物市场的发展。

行业发展和未来机遇:

全球复合药房市场主要参与者采取的各种举措如下:

    < li>2021 年 4 月,Quantrix Corp. 宣布与领先的行业专家举行网络研讨会,讨论与 pTau181、pTau217、pTau231 和其他神经生物标志物超灵敏定量相关的神经学进展。
  • 2020 年 8 月,强生公司Johnson Services, Inc. 和 Enigma Biomedical Group 签署了一项协议,评估新型神经影像生物标志物 JNJ-64413739 和 JNJ-64511070,以了解阿尔茨海默病和其他痴呆症。

竞争格局和主要公司:

神经生物标记物市场的一些知名参与者 Thermo Fisher Scientific Inc.、Abbott、 Myriad Genetics, Inc.、Bio-Rad Laboratories, Inc.、Qiagen、Banyan Biomarkers, Inc.、Immunarray Pvt. Ltd.、Quest Diagnostics Incorporated、PerkinElmer, Inc. 和 Merck Millipore 等是复合药房市场的领先公司。这些公司专注于各种增长战略,如合作、产品发布、业务扩张、协议等,以保持其在全球市场的地位。他们在全球范围内拥有广泛的业务,使他们能够为大量客户提供服务,并随后增加其神经生物标记物的市场份额。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the restraining factors for the neurological biomarkers market across the globe?

The concerns associated with biomarkers is the significant factor that will impede the neurological biomarkers market growth.

What are the driving factors for the neurological biomarkers market across the globe?

The global neurological biomarkers market is being driven by factors such as rising prevalence of neurological diseases and growing focus on neurological biomarker research. Furthermore, increasing awareness of neurological diseases coupled with developing healthcare infrastructure is likely to offer significant opportunities for the growth of the global neurological biomarkersmarket.

What are the neurological biomarkers?

Biomarkers are the molecules that indicate the presence of a disease. The biomarkers of the neurological disorders were not that accessible in earlier days. However, the advancements in the technology have enabled to track the health condition of the brain by measuring the biomarkers. This helps in the earlier detection of disease, less invasive diagnostics and allows faster drug development and is expected to be the effective treatment.

The List of Companies - Neurological Biomarkers Market

  1. Thermo Fisher Scientific Inc.
  2. Abbott
  3. Myriad Genetics, Inc.
  4. Bio-Rad Laboratories Inc.
  5. QIAGEN
  6. Banyan Biomarkers, Inc
  7. Immunarray Pvt. Ltd.
  8. Quest Diagnostics Incorporated
  9. Perkin Elmer, Inc.
  10. MERCK KGaA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports